title: Meningococcal polysaccharide vaccination of military recruits in Israel: preliminary assessment of vaccine effect.
abstract: Meningococcal disease in the Israel Defense Force is caused mainly by serogroups C and Y. Immunization of recruits with quadrivalent polysaccharide vaccine was introduced in November 1994. The person-time incidence rate dropped from 1.33 cases per 100,000 person-years for the preceding decade to 0 for the 32 months following immunization (p = 0.025).
authors.affiliation: Medical Corps, Israel Defense Force, Ramat-Hasharon, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Mimouni
authors.forename: M
authors.initials: M
authors.lastname: Gdalevich
authors.forename: Y
authors.initials: Y
authors.lastname: Mandel
authors.forename: M
authors.initials: M
authors.lastname: Haim
authors.forename: I
authors.initials: I
authors.lastname: Ashkenazi
authors.forename: J
authors.initials: J
authors.lastname: Shemer
authors.forename: C
authors.initials: C
authors.lastname: Block
mesh_terms: D000293:Adolescent; D000328:Adult; D001428:Bacterial Vaccines / Q000276:immunology*; D005260:Female; D006801:Humans; D007557:Israel / Q000453:epidemiology; D008297:Male; D008589:Meningococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D008875:Middle Aged; D008889:Military Personnel; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012703:Serotyping; D014611:Vaccination
chemical_list: D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial